Epigenic Therapeutics
- Business Model
- B2B
- Website
- epigenictx.com
- Total Funding
- $80.0M
- Last Round
- $20.0M AngelFeb 2025
- Rounds
- 3
About
Frontier biotechnology company developing next-generation gene modulation therapies utilizing epigenetic engineering for disease treatment.
Summary
Epigenic Therapeutics is a Biotech company. It has raised $80.0M in total across 3 rounds, most recently a $20.0M Angel round in Feb 2025. Investors include Morningside Venture Investments, Qiming VP and OrbiMed.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company